Using Topological Indices to Predict Anti-Alzheimer and Anti-parasitic GSK-3 Inhibitors by Multi-target QSAR in Silico Screening

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2010 Aug 18

PMID 20714305

Citations 9

Authors

Isela Garcia

Yagamare Fall

Generosa Gomez

Affiliations

Soon will be listed here.

Abstract

Plasmodium falciparum, Leishmania, Trypanosomes, are the causers of diseases such as malaria, leishmaniasis and African trypanosomiasis that nowadays are the most serious parasitic health problems worldwide. The great number of deaths and the few drugs available against these parasites, make necessary the search for new drugs. Some of these antiparasitic drugs also are GSK-3 inhibitors. GSKI-3 are candidates to develop drugs for the treatment of Alzheimer's disease. In this work topological descriptors for a large series of 3,370 active/non-active compounds were initially calculated with the ModesLab software. Linear Discriminant Analysis was used to fit the classification function and it predicts heterogeneous series of compounds like paullones, indirubins, meridians, etc. This study thus provided a general evaluation of these types of molecules.

Citing Articles

Multitarget Compounds for Neglected Diseases: A Review.

de Sousa N, Sousa G, Lima N, Bezerra de Assis E, Aragao M, de Moura E Curr Drug Targets. 2024; 25(9):577-601.

PMID: 38967077 DOI: 10.2174/0113894501298864240627060247.

Network pharmacology analysis reveals neuroprotection of Gynostemma pentaphyllum (Thunb.) Makino in Alzheimer' disease.

Wang J, Shi J, Jia N, Sun Q BMC Complement Med Ther. 2022; 22(1):57.

PMID: 35255879 PMC: 8902721. DOI: 10.1186/s12906-022-03534-z.

PTML Modeling for Pancreatic Cancer Research: In Silico Design of Simultaneous Multi-Protein and Multi-Cell Inhibitors.

Kleandrova V, Speck-Planche A Biomedicines. 2022; 10(2).

PMID: 35203699 PMC: 8962338. DOI: 10.3390/biomedicines10020491.

In Silico Drug Repurposing for Anti-Inflammatory Therapy: Virtual Search for Dual Inhibitors of Caspase-1 and TNF-Alpha.

Speck-Planche A, Kleandrova V, Scotti M Biomolecules. 2021; 11(12).

PMID: 34944476 PMC: 8699067. DOI: 10.3390/biom11121832.

On Molecular Descriptors of Carbon Nanocones.

Nazeer W, Farooq A, Younas M, Munir M, Kang S Biomolecules. 2018; 8(3).

PMID: 30205520 PMC: 6164578. DOI: 10.3390/biom8030092.

References

Gonzalez-Diaz H, Gonzalez-Diaz Y, Santana L, Ubeira F, Uriarte E . Proteomics, networks and connectivity indices. Proteomics. 2008; 8(4):750-78. DOI: 10.1002/pmic.200700638. View

Simon D, Benitez M, Gimenez-Cassina A, Garrido J, Bhat R, Diaz-Nido J . Pharmacological inhibition of GSK-3 is not strictly correlated with a decrease in tyrosine phosphorylation of residues 216/279. J Neurosci Res. 2007; 86(3):668-74. DOI: 10.1002/jnr.21523. View

. Discrimination and molecular design of new theoretical hypolipaemic agents using the molecular connectivity functions. J Chem Inf Comput Sci. 2000; 40(1):178-84. DOI: 10.1021/ci9900480. View

Arana B, Rizzo N, Diaz A . Chemotherapy of cutaneous leishmaniasis: a review. Med Microbiol Immunol. 2002; 190(1-2):93-5. DOI: 10.1007/s004300100089. View

Cohen P, Frame S . The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001; 2(10):769-76. DOI: 10.1038/35096075. View

Marrero-Ponce Y, Meneses-Marcel A, Castillo-Garit J, Machado-Tugores Y, Escario J, Barrio A . Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs. Bioorg Med Chem. 2006; 14(19):6502-24. DOI: 10.1016/j.bmc.2006.06.016. View

Copeland R, Pompliano D, Meek T . Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov. 2006; 5(9):730-9. DOI: 10.1038/nrd2082. View

Caballero J, Fernandez M . Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1). Curr Top Med Chem. 2008; 8(18):1580-605. DOI: 10.2174/156802608786786570. View

Ponce Y, Diaz H, Zaldivar V, Torrens F, Castro E . 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities. Bioorg Med Chem. 2004; 12(20):5331-42. DOI: 10.1016/j.bmc.2004.07.051. View

10.

Khan M . Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Curr Drug Metab. 2010; 11(4):285-95. DOI: 10.2174/138920010791514306. View

11.

Bryceson A . Current issues in the treatment of visceral leishmaniasis. Med Microbiol Immunol. 2002; 190(1-2):81-4. DOI: 10.1007/s004300100086. View

12.

Brion J, Anderton B, Authelet M, Dayanandan R, Leroy K, Lovestone S . Neurofibrillary tangles and tau phosphorylation. Biochem Soc Symp. 2001; (67):81-8. DOI: 10.1042/bss0670081. View

13.

Prado-Prado F, Ubeira F, Borges F, Gonzalez-Diaz H . Unified QSAR & network-based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks. J Comput Chem. 2009; 31(1):164-73. DOI: 10.1002/jcc.21292. View

14.

Concu R, Dea-Ayuela M, Perez-Montoto L, Bolas-Fernandez F, Prado-Prado F, Podda G . Prediction of enzyme classes from 3D structure: a general model and examples of experimental-theoretic scoring of peptide mass fingerprints of Leishmania proteins. J Proteome Res. 2009; 8(9):4372-82. DOI: 10.1021/pr9003163. View

15.

Nikoulina S, Ciaraldi T, Mudaliar S, Mohideen P, Carter L, Henry R . Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes. 2000; 49(2):263-71. DOI: 10.2337/diabetes.49.2.263. View

16.

Prado-Prado F, Gonzalez-Diaz H, Santana L, Uriarte E . Unified QSAR approach to antimicrobials. Part 2: predicting activity against more than 90 different species in order to halt antibacterial resistance. Bioorg Med Chem. 2006; 15(2):897-902. DOI: 10.1016/j.bmc.2006.10.039. View

17.

Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59. DOI: 10.1007/BF00308809. View

18.

Xiao J, Guo Z, Guo Y, Chu F, Sun P . Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses. Protein Eng Des Sel. 2005; 19(2):47-54. DOI: 10.1093/protein/gzi074. View

19.

Liao J . Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. J Med Chem. 2007; 50(3):409-24. DOI: 10.1021/jm0608107. View

20.

Dajani R, Fraser E, Roe S, Young N, Good V, Dale T . Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell. 2001; 105(6):721-32. DOI: 10.1016/s0092-8674(01)00374-9. View